Dongbao Bio-Tech
3002394.771.49% ( +0.07 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Dongbao Bio-Tech(300239) the Revenue is 190.53 M (+1.32%);the EBIT is 25.97 M (+7.52%);the EPS is 0.0306 (+3.03%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.19B1.32%
----
----
EBIT
0.03B7.52%
----
----
EPS
0.03063.03%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf